Donald Notman

Insider Reports History

Location
Bedford, MA
Signature
/s/ Todd Anderman, Attorney-in-Fact for Donald Notman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Donald Notman:

Company Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Financial Officer and Chief Operating Officer. Common Stock 389,292 $4,241,258 $10.89 02 Jan 2026 Direct
OCULAR THERAPEUTIX, INC Chief Financial Officer and Chief Operating Officer. Stock Option (Right to Buy) 240,932 02 Jan 2026 Direct

Insider Reports Filed by Donald Notman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCUL OCULAR THERAPEUTIX, INC 02 Jan 2026 2 $0 4 Chief Financial Officer and Chief Operating Officer. 06 Jan 2026, 16:01
OCUL OCULAR THERAPEUTIX, INC 02 Sep 2025 1 -$13,250 4 Chief Financial Officer and Chief Operating Officer. Exhibit Index Exhibit 24 - Power of Attorney 04 Sep 2025, 16:50
OCUL OCULAR THERAPEUTIX, INC 11 Feb 2025 2 $0 4 Chief Financial Officer and Chief Operating Officer 13 Feb 2025, 20:36
OCUL OCULAR THERAPEUTIX, INC 31 Jan 2025 2 -$136,239 4 Chief Financial Officer and Chief Operating Officer 04 Feb 2025, 19:16
OCUL OCULAR THERAPEUTIX, INC 29 Aug 2024 2 $0 4 Chief Operating Officer and Chief Financial Officer 03 Sep 2024, 16:08
OCUL OCULAR THERAPEUTIX, INC 03 Feb 2024 3 +$30,190 4 Chief Financial Officer 06 Feb 2024, 18:29
OCUL OCULAR THERAPEUTIX, INC 31 Jan 2024 1 -$31,843 4 Chief Financial Officer 02 Feb 2024, 19:03
OCUL OCULAR THERAPEUTIX, INC 06 Feb 2023 1 -$27,458 4 Chief Financial Officer 08 Feb 2023, 18:32
OCUL OCULAR THERAPEUTIX, INC 30 Jan 2023 2 $0 4 Chief Financial Officer 01 Feb 2023, 18:33
OCUL OCULAR THERAPEUTIX, INC 03 Feb 2022 2 $0 4 Chief Financial Officer 07 Feb 2022, 18:34